Patent · US Active

Tissue thickness compensators comprising therapeutic agents

US9572574B2 · kind B2 · utility

1,105Cited by
2,569References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 22, 2015
Grant dateFeb 21, 2017
Priority date
Expiry dateJun 22, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2017/2937
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

An end effector is disclosed. The end effector comprises a first jaw, a second jaw, wherein at least one of the first jaw and the second jaw is movable to compress tissue between the first jaw and the second jaw, and a cartridge body configured to receive a cutting member. The end effector further comprises a layer arrangement including a tissue contact surface and a plurality of therapeutic agents releasably contained within the layer arrangement, wherein each therapeutic agent is configured to either initially treat the tissue or sustainably treat the tissue in contact with the tissue contact surface, wherein one of the plurality of therapeutic agents is configured to be released by the cutting member, and wherein another of the plurality of therapeutic agents is configured to be released by an absorption process.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.